Kratom is an herbal substance derived from Mitragyna speciosa, which has grown widely in popularity across the U.S. and globally. Advocates swear by its potential to boost energy, ease pain, or help with opioid withdrawal. But what does long‑term research actually tell us about kratom’s relationship to the liver?
In this article, we examine the latest longitudinal findings, regulatory perspectives, and clinical evidence to separate data from anecdote.
What Is Kratom?
Kratom is a plant from Southeast Asia that people have traditionally used as a stimulant in small amounts and as a sedative or pain reliever in larger doses. Its active compounds include mitragynine and 7‑hydroxymitragynine. They interact with opioid receptors and other parts of the nervous system.
Despite its growing popularity, the U.S. Food and Drug Administration (FDA) has not approved kratom as a drug or dietary supplement and warns that it may cause serious side effects, including liver damage.
Click here to know more:
How the Liver Metabolizes Kratom
Understanding liver metabolism is key to interpreting study results:
-
The liver breaks down many substances, including kratom’s active alkaloids.
-
Some byproducts may be innocuous, while others can stress hepatic systems.
-
Individuals vary in metabolic capacity, which affects how their liver responds to repeated kratom use.
The FDA still highlights that research on how kratom affects human liver metabolism remains limited.
Types of Liver Reactions Linked to Kratom
Studies and clinical reports discuss a few patterns:
Acute Liver Injury
Multiple case reports and observational studies have linked regular kratom use to sudden liver injury. Common symptoms appear within weeks and can include jaundice (yellowing of the skin and eyes), fatigue, dark urine, nausea, and itching.
Cholestatic Injury
Several case studies reported cholestatic liver injury, where bile flow is blocked. These cases often showed high bilirubin levels and temporary enlargement of the bile ducts.
Severe Liver Failure
In rare but serious cases, kratom use has been linked to fulminant liver failure that requires intensive medical treatment. For example, in 2024, a patient with severe jaundice and liver failure caused by kratom was successfully treated with plasma exchange, highlighting the potential seriousness of its effects.
Longitudinal Evidence: What Studies Show
Here’s a breakdown of the most relevant longitudinal findings as of 2026.
National Drug-Induced Liver Injury Network Data
A notable U.S. study from the Drug-Induced Liver Injury Network tracked 11 cases of kratom-related liver injury. Symptoms usually appeared within about 14 days of regular use, and all patients recovered after stopping kratom and receiving supportive care. Although it's not a large population study, this cohort is one of the few to follow real-world liver outcomes over time, rather than relying on isolated case reports.
Case Reviews and Longitudinal Patterns
Comprehensive reviews of multiple kratom-related liver injury cases show:
-
Rapid Symptom Onset: The median onset of liver-related symptoms occurs approximately 20 days after initial use.
-
Enzyme Elevations: Clinical presentations typically involve a combined elevation of cholestatic and hepatocellular enzymes.
-
Established Causal Link: Individual cases differ, but the overall evidence supports a causal link between kratom use and liver injury in susceptible individuals.
-
Data Limitations: Many existing studies lack uniform causality assessment methods, which makes it difficult to precisely quantify the overall risk to the general population.
Recent 2025–2026 Developments
Below are the most recent data points shaping the 2026 perspective:
2024‑2025 Herbal Supplement Liver Injury Trends
A 2024 review of herbal and dietary supplement–induced liver injuries highlighted that kratom is among several supplements increasingly linked to DILI (drug‑induced liver injury). Although kratom cases still represent a minority compared to other supplements, the trend underscores its growing recognition in clinical settings.
Regulatory and Safety Signals
In early 2026, local public health departments issued warnings about potent opioid derivatives, such as 7‑hydroxymitragynine, in kratom products, noting that unregulated formulations may raise the risk of adverse effects, including liver damage.
THC/Cannabis Research Offers Parallel Insights
CBHD.news recently reported on facts related to liver and kratom. This article sheds light on Kratom’s impact on liver health, driving industry shifts toward safety validation, advanced testing, and pharmaceutical-grade standards in 2026.
Click here to know how Kratom affects the liver.
Kratom Side Effects | Does Kratom Damage Your Liver? | Dr. Oliver Grundmann
Who Is Most at Risk?
Based on the available evidence:
-
Dosage and Duration: Reported cases of liver injury occur more frequently among chronic and high-dose users.
-
Preexisting Conditions: People with preexisting liver disease may be more susceptible to adverse outcomes and liver stress.
-
Product Quality and Purity: Unregulated products have a higher risk due to potential contaminants (like heavy metals or bacteria) or excessively high concentrations of opioid-like alkaloids (such as 7-hydroxymitragynine).
By contrast, some longitudinal observational discussion groups and anecdotal reports note that many long-term kratom users show no abnormal liver findings. However, these observations cannot replace controlled clinical research.
Important: Anecdotal reports do not substitute for medical evidence and can have selection and reporting biases.
Mechanisms Still Not Fully Understood
Even though people have used kratom for a long time, scientists still aren’t exactly sure how it can hurt the liver.
-
The Cause is a Mystery: Researchers don't know if the damage is caused by the plant’s natural ingredients, the way the body processes those ingredients, or if the products are accidentally contaminated.
-
It’s Unpredictable: Science hasn't found a clear reason why some people get sick while many others do not. It seems to happen randomly to a small number of users.
-
Why Health Officials are Worried: Because there are so many unanswered questions, regulators are telling people to be very careful until more testing is done.
There are still so many unanswered questions. Health officials are telling people to be extra careful. They want to see more high-quality scientific studies before they can say for sure how kratom affects the liver and who might be at risk.
Practical Takeaways for Readers
Before moving to the conclusion, here’s what the science indicates in practical terms:
-
Liver Injury is Rare but Real: Medical records show documented cases where liver enzymes spike, and jaundice (yellowing of the eyes or skin) appears within just a few weeks of starting use.
-
Patterns are Emerging: Long-term tracking of user groups supports these findings, though larger and more detailed studies are still needed to know exactly how common these risks are.
-
Unregulated Products are Risky: Because these products aren't always tested, they may contain contaminants or inconsistent levels of strong compounds that could lead to unexpected health problems.
-
Health Agencies are Staying Cautious: The FDA and other public health groups remain wary because there isn't enough standardized data yet to answer all the safety questions.
Conclusion
By 2026, long-term studies show that kratom can cause liver damage in a small number of people, usually within a few weeks of regular use.
While most people recover once they stop taking it, there have been rare cases of severe illness. Because of this, more consistent research and stronger safety rules are needed to truly understand the risks.